Znomics

Znomics was a biotechnology company specializing in the use of zebrafish as a model organism for drug discovery and functional genomics. The company's platform leveraged the genetic and physiological similarities between zebrafish and humans to conduct high-throughput screening of small molecules. Its proprietary technology allowed for the rapid identification of gene functions and the evaluation of drug safety and efficacy in a whole-animal system. Znomics primarily targeted therapeutic areas including central nervous system disorders, oncology, and metabolic diseases. The company was founded based on research from the Oregon Health & Science University and was headquartered in Portland, Oregon. In 2009, Znomics was acquired by the Australian biopharmaceutical firm Bionomics to enhance its drug discovery capabilities and pipeline.